Chinese stocks could rally 15% as more stimulus spurs a GDP growth spurt next year, SocGen says
Fiscal stimulus in China could help boost the world's second-largest economy to 5% GDP growth next year, SocGen analysts ...
Stock market today: Dow notches record high after strong jobs report eases slowdown worries
Odds of a 50 basis point cut dropped to 0% from 53% last week after the strong September jobs report, according to the CME ...
There's a simple reason one of Wall Street's most bullish strategists expects a 40% rise in the S&P 500 by 2030
"EPS could double to $400 by the end of the decade in our Roaring 2020s scenario," Ed Yardeni said in a recent note.
Medicare shake-up sends Humana stock down 23% in a week for its worst drop since 2009
Medicare plans to downgrade ratings on some of the Humana's health insurance plans. The stock has fallen 23% for its worst ...
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million
OnKure is focused on advancing a pipeline of candidates targeting oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kα), initially in ...
VERB Stockholders Vote To Reverse Split VERB Shares To Retain Nasdaq Listing
Verb Technology Company, Inc. (Nasdaq: VERB) ("VERB" or the "Company"), the leader in interactive video-based sales-enablement applications, including MARKET.live, its livestream social shopping ...
FORD MONDAY DEADLINE: Ford Motor Company (F) Investors that Lost Money are Alerted to Contact BFA Law before the October 7 Court Deadline Expires
New York, New York-- (Newsfile Corp. - October 4, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Ford Motor Company (NYSE: F) and ...
Capricor Therapeutics to Present Long-Term Data from HOPE-2 Open Label Extension Study at 2024 World Muscle Society Congress
Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, announced today that the Company will ...
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells, today ...
TeraWulf Inc (WULF) Receives a Buy from Stifel Nicolaus
Stifel Nicolaus analyst Bill Papanastasiou maintained a Buy rating on TeraWulf Inc (WULF – Research Report) today and set a price target ...